Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-091829
Filing Date
2025-06-30
Accepted
2025-06-30 20:15:05
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 20014
  Complete submission text file 0000950170-25-091829.txt   24375
Mailing Address BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 251093826

Mailing Address BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 251093827

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Reporting) CIK: 0001263508 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 251093831

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 212-339-5600
Baker Brothers Life Sciences LP (Reporting) CIK: 0001363364 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 251093828

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 212-339-5600
667, L.P. (Reporting) CIK: 0001551139 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 251093830

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 (212)339-5600
Baker Bros. Advisors (GP) LLC (Reporting) CIK: 0001580575 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 251093829

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)